Search Results for

stroke

351-400 of 3062 Results
Sort by Relevance , Date , Title

afp20130615od1.pdf

...initiative sponsored by the U.S. Department of Health and Human Services that aims to decrease the number of heart attacks and strokes by 1 million over the next five years. It emphasizes the use of effective clinical preventive services combined with multifaceted policy inter-...

American Family Physician

https://www.aafp.org/afp/2013/0615/afp20130615od1.pdf

afp20130701p20.pdf

...Evidence-Based Answer Pharmacologic treatment of mild hypertension for up to five years does not reduce coronary events, stroke, or mortality compared with placebo. (Strength of Recom- mendation: B, based on inconsistent or limited-quality patient-oriented evidence.) Practice...

American Family Physician

https://www.aafp.org/afp/2013/0701/afp20130701p20.pdf

afp20130701p21.pdf

...Evidence-Based Answer Pharmacologic treatment of mild hypertension for up to five years does not reduce coronary events, stroke, or mortality compared with placebo. (Strength of Recom- mendation: B, based on inconsistent or limited-quality patient-oriented evidence.) Practice...

American Family Physician

https://www.aafp.org/afp/2013/0701/afp20130701p21.pdf

afp20130701p61.pdf

...Endovascular Therapies Do Not Improve Outcomes in Acute Stroke Clinical Question Does adding endovascular procedures to intravenous tissue plasminogen activator (t-PA) improve outcomes for patients with stroke? Bottom Line Endovascular therapies (local delivery of t-PA,...

American Family Physician

https://www.aafp.org/afp/2013/0701/afp20130701p61.pdf

afp20130801p164.pdf

...blood cells for arbitrary hemoglobin or hematocrit thresholds and in the absence of symptoms or active coronary disease, heart failure, or stroke.7 AABB guideline Don’t do workup for clotting disorder (order hypercoagulable testing) for patients who develop first episode of...

American Family Physician

https://www.aafp.org/afp/2013/0801/afp20130801p164.pdf

afp20130801p201.pdf

...diet screener, the Mediterranean diet groups had higher scores. The primary outcome was a combined end point of myocardial infarction, stroke, and cardiovascular death. This end point was less likely for both of the Mediterranean diet groups than for the low-fat diet con- trol...

American Family Physician

https://www.aafp.org/afp/2013/0801/afp20130801p201.pdf

afp20130815p231.pdf

...daytime sleepiness, obesity, treatment- refractory hypertension, need for bariatric surgery, atrial fibrillation, congestive heart failure, stroke, nocturnal cardiac dysrhythmias, type 2 diabetes mellitus, and pulmonary hypertension. If OSA is suspected, a referral for...

American Family Physician

https://www.aafp.org/afp/2013/0815/afp20130815p231.pdf

afp20130815p269.pdf

...Active or recent (within the past year) arterial thromboembolic disease (e.g., stroke, myocardial infarction) Liver dysfunction or disease Known thrombophilic disorders (e.g., protein C, protein S, antithrombin deficiency) Known hypersensitivity to any of the ingredients in...

American Family Physician

https://www.aafp.org/afp/2013/0815/afp20130815p269.pdf

afp20130901p333.pdf

...out- come among patients in the aliskiren group. This composite included cardiovascular death, cardiac arrest, myocardial infarction, stroke, unplanned hospitalization for heart failure, end-stage renal disease or death due to renal failure, or doubling of serum creatinine levels....

American Family Physician

https://www.aafp.org/afp/2013/0901/afp20130901p333.pdf

afp20130901p333a.pdf

...out- come among patients in the aliskiren group. This composite included cardiovascular death, cardiac arrest, myocardial infarction, stroke, unplanned hospitalization for heart failure, end-stage renal disease or death due to renal failure, or doubling of serum creatinine levels....

American Family Physician

https://www.aafp.org/afp/2013/0901/afp20130901p333a.pdf

afp20130901p334.pdf

...out- come among patients in the aliskiren group. This composite included cardiovascular death, cardiac arrest, myocardial infarction, stroke, unplanned hospitalization for heart failure, end-stage renal disease or death due to renal failure, or doubling of serum creatinine levels....

American Family Physician

https://www.aafp.org/afp/2013/0901/afp20130901p334.pdf

afp20130901p337.pdf

...out- come among patients in the aliskiren group. This composite included cardiovascular death, cardiac arrest, myocardial infarction, stroke, unplanned hospitalization for heart failure, end-stage renal disease or death due to renal failure, or doubling of serum creatinine levels....

American Family Physician

https://www.aafp.org/afp/2013/0901/afp20130901p337.pdf

afp20131015od4.pdf

...29,873 patients who were followed for up to five years. The rates of the compos- ite outcome of death or hospitalization for heart failure, stroke, or myocardial infarc- tion were low and similar in both groups: 3.2 to 3.4 events per 100 persons per year of follow-up. However,...

American Family Physician

https://www.aafp.org/afp/2013/1015/afp20131015od4.pdf

afp20131115p676-s1.pdf

...How is GCA treated? GCA requires higher doses of steroids. This will help lower your risk of going blind, having a stroke, or other problems. Your doctor may start you on steroids even before he or she is sure you have GCA. Symptoms improve quickly over a few days, but sometimes,...

American Family Physician

https://www.aafp.org/afp/2013/1115/afp20131115p676-s1.pdf

afp20131215od1.pdf

...(0.73% intervention vs. 0.86% control) and a composite primary outcome of cardiovascular death, nonfatal myocardial infarction, nonfatal stroke, or hospitalization for angina (1.83% intervention vs. 1.92% control). Most of the individual outcomes had relative risks of less than 1.0,...

American Family Physician

https://www.aafp.org/afp/2013/1215/afp20131215od1.pdf

afp20131215p821.pdf

...is more effective than clopido- grel in the combined outcome of prevent- ing death from vascular causes, myocardial infarction, and stroke over the course of one year (9.8% vs. 11.7%; number needed to treat = 60; 95% confidence interval, 40 to 126).1 All-cause mortality was also...

American Family Physician

https://www.aafp.org/afp/2013/1215/afp20131215p821.pdf

afp20140201p224.pdf

...infarction risk, or stroke risk? Bottom Line Population-based screening for heart dis- ease or valve disease with echocardiography will identify cardiac pathology in patients but does not decrease mortality, myocardial infarction risk, or stroke risk. (Level of Evi- dence = 1b)...

American Family Physician

https://www.aafp.org/afp/2014/0201/afp20140201p224.pdf

afp20140201p225.pdf

...infarction risk, or stroke risk? Bottom Line Population-based screening for heart dis- ease or valve disease with echocardiography will identify cardiac pathology in patients but does not decrease mortality, myocardial infarction risk, or stroke risk. (Level of Evi- dence = 1b)...

American Family Physician

https://www.aafp.org/afp/2014/0201/afp20140201p225.pdf

afp20140201p226.pdf

...infarction risk, or stroke risk? Bottom Line Population-based screening for heart dis- ease or valve disease with echocardiography will identify cardiac pathology in patients but does not decrease mortality, myocardial infarction risk, or stroke risk. (Level of Evi- dence = 1b)...

American Family Physician

https://www.aafp.org/afp/2014/0201/afp20140201p226.pdf

afp20140401p574.pdf

...had hyperlipidemia and approximately 30% had diabetes. The primary outcome was a composite of death from cardiovascular or renal causes, stroke, myocardial infarction, hospitalization for acute heart failure, wors- ening renal insufficiency, or the need for permanent dialysis. At a...

American Family Physician

https://www.aafp.org/afp/2014/0401/afp20140401p574.pdf

afp20140401p574a.pdf

...had hyperlipidemia and approximately 30% had diabetes. The primary outcome was a composite of death from cardiovascular or renal causes, stroke, myocardial infarction, hospitalization for acute heart failure, wors- ening renal insufficiency, or the need for permanent dialysis. At a...

American Family Physician

https://www.aafp.org/afp/2014/0401/afp20140401p574a.pdf

afp20140401p576.pdf

...had hyperlipidemia and approximately 30% had diabetes. The primary outcome was a composite of death from cardiovascular or renal causes, stroke, myocardial infarction, hospitalization for acute heart failure, wors- ening renal insufficiency, or the need for permanent dialysis. At a...

American Family Physician

https://www.aafp.org/afp/2014/0401/afp20140401p576.pdf

afp20140401p578.pdf

...had hyperlipidemia and approximately 30% had diabetes. The primary outcome was a composite of death from cardiovascular or renal causes, stroke, myocardial infarction, hospitalization for acute heart failure, wors- ening renal insufficiency, or the need for permanent dialysis. At a...

American Family Physician

https://www.aafp.org/afp/2014/0401/afp20140401p578.pdf

afp20140615p936.pdf

...recent study. These complications include the incidence of lower-extremity amputation, end-stage renal disease, acute myocardial infarction, stroke, and deaths from hyperglycemic crisis. According to CDC researchers, possible reasons for the decline include an increased emphasis on...

American Family Physician

https://www.aafp.org/afp/2014/0615/afp20140615p936.pdf

afp20140815od2.pdf

...of hypertension and stroke. Diclofenac does not increase the risk of hypertension, but does increase the risk of stroke. Naproxen (Naprosyn) does not increase the risk of hypertension or stroke. Celecoxib (Celebrex) does not increase the risk of hypertension or stroke. Evidence...

American Family Physician

https://www.aafp.org/afp/2014/0815/afp20140815od2.pdf

afp20140815p260.pdf

...lipoprotein cholesterol (LDL-C) and an increased risk of atherosclerotic car- diovascular disease (ASCVD), including coronary heart disease, stroke, and peripheral arterial disease. Random- ized controlled trials (RCTs) have found that treating with statins reduces ASCVD events....

American Family Physician

https://www.aafp.org/afp/2014/0815/afp20140815p260.pdf

afp20140901p326a.pdf

...[CI], 2% to 22%), major cardiovascular events by 14% (95% CI, 5% to 33%), and heart failure by 19% (95% CI, 7% to 29%), and did not decrease stroke risk compared with placebo or other treatments. ARBs did not affect any of these outcomes other than heart failure (30% decrease; 95%...

American Family Physician

https://www.aafp.org/afp/2014/0901/afp20140901p326a.pdf

afp20140901p331.pdf

...[CI], 2% to 22%), major cardiovascular events by 14% (95% CI, 5% to 33%), and heart failure by 19% (95% CI, 7% to 29%), and did not decrease stroke risk compared with placebo or other treatments. ARBs did not affect any of these outcomes other than heart failure (30% decrease; 95%...

American Family Physician

https://www.aafp.org/afp/2014/0901/afp20140901p331.pdf

afp20140901p335.pdf

...[CI], 2% to 22%), major cardiovascular events by 14% (95% CI, 5% to 33%), and heart failure by 19% (95% CI, 7% to 29%), and did not decrease stroke risk compared with placebo or other treatments. ARBs did not affect any of these outcomes other than heart failure (30% decrease; 95%...

American Family Physician

https://www.aafp.org/afp/2014/0901/afp20140901p335.pdf

afp20150201p172-s1.pdf

...is it important to treat high blood pressure? Treatment is important because having high blood pressure increases your risk of heart attack, stroke, and heart failure. How is it detected? Your doctor can measure your blood pressure with a blood pressure cuff that goes around your...

American Family Physician

https://www.aafp.org/afp/2015/0201/afp20150201p172-s1.pdf

afp20150401p434.pdf

March 1, 2015 Editorials

American Family Physician

https://www.aafp.org/afp/2015/0401/afp20150401p434.pdf

afp20150501p625-s1.pdf

...if you smoke, talk with your doctor about birth control that has estrogen in it. These conditions may increase your risk of blood clots and stroke. Condoms are the only birth control method that decreases your risk of getting a sexually transmitted infection. Condoms can be used...

American Family Physician

https://www.aafp.org/afp/2015/0501/afp20150501p625-s1.pdf

afp20151001p556.pdf

...pulmo- nary disease, congestive heart failure, hypertension, cor- onary artery disease, or mood disorders. Patients with a history of stroke also will be included in the test model. According to CMS, the model will test the hypoth- esis that if Medicare Advantage plans offer...

American Family Physician

https://www.aafp.org/afp/2015/1001/afp20151001p556.pdf

afp20160201p177.pdf

February 1, 2016 Cochrane for Clinicians

American Family Physician

https://www.aafp.org/afp/2016/0201/afp20160201p177.pdf

afp20160301p410.pdf

...was 63 years, 71% were men, and 5% were black. This was a very high-risk group: 75% had coronary artery disease, 23% had a previous stroke, 20% had peripheral arterial disease, and 25% had a coronary artery bypass graft. The other hypoglycemic medications used by patients included...

American Family Physician

https://www.aafp.org/afp/2016/0301/afp20160301p410.pdf

afp20160301p411.pdf

...was 63 years, 71% were men, and 5% were black. This was a very high-risk group: 75% had coronary artery disease, 23% had a previous stroke, 20% had peripheral arterial disease, and 25% had a coronary artery bypass graft. The other hypoglycemic medications used by patients included...

American Family Physician

https://www.aafp.org/afp/2016/0301/afp20160301p411.pdf

afp20160501p738.pdf

...(A) Recommend aspirin use in women 55 to 79 years of age for reduction in ischemic stroke if benefit outweighs risk (I) IETRFOA aspirin for primary prevention of cardiovascular risk reduction in individuals 80 years and older (D) Recommend against use of aspirin for CVD...

American Family Physician

https://www.aafp.org/afp/2016/0501/afp20160501p738.pdf

afp20160615p1032.pdf

...Meta-Analysis: Intensive BP Control Decreases Major CV Events and Stroke, but Not MI, Heart Failure, or Mortality Clinical Question Does intensive lowering of blood pressure (BP) improve the lives of patients with hypertension? Bottom Line Patients with hypertension who are...

American Family Physician

https://www.aafp.org/afp/2016/0615/afp20160615p1032.pdf

afp20160615p1032a.pdf

...Meta-Analysis: Intensive BP Control Decreases Major CV Events and Stroke, but Not MI, Heart Failure, or Mortality Clinical Question Does intensive lowering of blood pressure (BP) improve the lives of patients with hypertension? Bottom Line Patients with hypertension who are...

American Family Physician

https://www.aafp.org/afp/2016/0615/afp20160615p1032a.pdf

afp20160615p1037.pdf

...Meta-Analysis: Intensive BP Control Decreases Major CV Events and Stroke, but Not MI, Heart Failure, or Mortality Clinical Question Does intensive lowering of blood pressure (BP) improve the lives of patients with hypertension? Bottom Line Patients with hypertension who are...

American Family Physician

https://www.aafp.org/afp/2016/0615/afp20160615p1037.pdf

afp20160901od1.pdf

September 1, 2016: Medicine by the Numbers

American Family Physician

https://www.aafp.org/afp/2016/0901/afp20160901od1.pdf

afp20160901p355-s1.pdf

...• Heart disease, including heart failure • Stroke • Hypertension (not controlled with medicine) • Depression • Increased risk of motor vehicle crashes • Overall increased risk of death Where can I get more information? Your doctor American Sleep Apnea Association...

American Family Physician

https://www.aafp.org/afp/2016/0901/afp20160901p355-s1.pdf

afp20160901p384.pdf

...Newer Sulfonylureas Not Associated with Increased Mortality, MIs, or Strokes Clinical Question Are newer-generation sulfonylureas associated with bad outcomes in patients with type 2 diabetes mellitus? Bottom Line In multiple randomized trials, the long-term use of second- or...

American Family Physician

https://www.aafp.org/afp/2016/0901/afp20160901p384.pdf

afp20160901p384a.pdf

...Newer Sulfonylureas Not Associated with Increased Mortality, MIs, or Strokes Clinical Question Are newer-generation sulfonylureas associated with bad outcomes in patients with type 2 diabetes mellitus? Bottom Line In multiple randomized trials, the long-term use of second- or...

American Family Physician

https://www.aafp.org/afp/2016/0901/afp20160901p384a.pdf

afp20160901p386.pdf

...Newer Sulfonylureas Not Associated with Increased Mortality, MIs, or Strokes Clinical Question Are newer-generation sulfonylureas associated with bad outcomes in patients with type 2 diabetes mellitus? Bottom Line In multiple randomized trials, the long-term use of second- or...

American Family Physician

https://www.aafp.org/afp/2016/0901/afp20160901p386.pdf

afp20160901p387.pdf

...Newer Sulfonylureas Not Associated with Increased Mortality, MIs, or Strokes Clinical Question Are newer-generation sulfonylureas associated with bad outcomes in patients with type 2 diabetes mellitus? Bottom Line In multiple randomized trials, the long-term use of second- or...

American Family Physician

https://www.aafp.org/afp/2016/0901/afp20160901p387.pdf

afp20160915p442-s1.pdf

...of your heart to shake, and not pump blood well. Sometimes a clot can form in this chamber, and if that clot breaks free it can cause a stroke. What are the symptoms? Your heartbeat may feel fast and uneven. You may also feel weak, tired, or short of breath. You may find it hard...

American Family Physician

https://www.aafp.org/afp/2016/0915/afp20160915p442-s1.pdf

afp20161101p691.pdf

November 1, 2016: Cochrane for Clinicians

American Family Physician

https://www.aafp.org/afp/2016/1101/afp20161101p691.pdf

afp20161101p692.pdf

November 1, 2016: Cochrane for Clinicians

American Family Physician

https://www.aafp.org/afp/2016/1101/afp20161101p692.pdf

afp20161115p820-s1.pdf

...to the nerves and blood vessels in the penis. This allows the penis to fill with blood. Some medical conditions block these signals, such as strokes, spine or pelvic injuries, Parkinson disease, and multiple sclerosis. Nerve damage from diabetes or prostate surgery can also cause...

American Family Physician

https://www.aafp.org/afp/2016/1115/afp20161115p820-s1.pdf

25 50 100 results per page